Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Workday Q1 Loss Widens; Lifts FY14 Revenue Outlook - Quick Facts

RELATED NEWS
Trade WDAY now with 

Workday Inc. (WDAY: Quote), a provider of enterprise cloud-based applications, Wednesday reported first-quarter net loss attributable to common stockholders of $33.0 million, wider than $20.3 million in the year-ago period. Loss per share for the quarter narrowed to $0.20 from $0.61 in the previous year quarter.

Excluding items, loss for the quarter was $24.9 million, wider than $18.6 million last year. Loss per share for the latest first quarter narrowed to $0.15 from $0.57 in the comparable quarter last year.

Revenues for the quarter rose to $91.65 million from $56.82 million a year ago.

On average, analysts polled by Thomson Reuters estimated a loss of $0.18 per share on revenues of $86.91 million for the quarter. Analysts' estimates typically exclude special items.

Looking ahead to the second quarter of fiscal year 2014, the company expects revenues of $97 million to $101 million, or growth of 55% to 61% from the prior year. Analysts currently estimate revenues of $99.00 million.

For fiscal year 2014, the company expects revenues of $425 million to $440 million, or a growth of 75% to 80% from last year. Analysts currently expect revenues of $433.25 million.

Previously, the company expected fiscal 2014 revenues of $420 million to $435 million.

Register
To receive FREE breaking news email alerts for Workday Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.